Matches in SemOpenAlex for { <https://semopenalex.org/work/W2523096729> ?p ?o ?g. }
- W2523096729 endingPage "509" @default.
- W2523096729 startingPage "498" @default.
- W2523096729 abstract "Aim The objective of this population pharmacokinetic (PK) analysis was to provide guidance for the dosing interval of daptomycin in patients undergoing continuous renal replacement therapy (CRRT). Methods A previously published population PK model for daptomycin was updated with data from patients undergoing continuous veno-venous haemodialysis (CVVHD; n = 9) and continuous veno-venous haemodiafiltration (CVVHDF; n = 8). Model-based simulations were performed to compare the 24 h AUC, Cmax and Cmin of daptomycin following various dosing regimens (4, 6, 8, 10, and 12 mg kg−1 every [Q] 24 h and Q48 h), with the safety and efficacy exposure references for Staphylococcus aureus bacteraemia/right-sided infective endocarditis. Results The previously developed daptomycin structural population PK model could reasonably describe data from the patients on CRRT. The clearance in patients undergoing CVVHDF and CVVHD was estimated at 0.53 and 0.94 l h−1, respectively, as compared with 0.75 l h−1 in patients with creatinine clearance (CrCl) ≥ 30 ml min−1. Daptomycin Q24 h dosing in patients undergoing CRRT resulted in optimal exposure for efficacy, with AUC comparable to that in patients with CrCl ≥ 30 ml min−1. In contrast, Q48 h dosing was associated with considerably lower AUC24–48h in all patients for doses up to 12 mg kg−1 and is therefore inappropriate. Conclusions Q24 h dosing of daptomycin up to 12 mg kg−1 provides comparable drug exposure in patients on CVVHD and in those with CrCl ≥ 30 ml min−1. Daily daptomycin use up to 8 mg kg−1 doses are appropriate for patients on CVVHDF, but higher doses may increase the risk of toxicity." @default.
- W2523096729 created "2016-09-30" @default.
- W2523096729 creator A5031789038 @default.
- W2523096729 creator A5036932318 @default.
- W2523096729 creator A5048242996 @default.
- W2523096729 creator A5065844847 @default.
- W2523096729 creator A5076511543 @default.
- W2523096729 creator A5078802906 @default.
- W2523096729 creator A5080990092 @default.
- W2523096729 date "2016-10-28" @default.
- W2523096729 modified "2023-10-10" @default.
- W2523096729 title "Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy" @default.
- W2523096729 cites W1967192706 @default.
- W2523096729 cites W1974227486 @default.
- W2523096729 cites W1974903759 @default.
- W2523096729 cites W1979827269 @default.
- W2523096729 cites W1979827848 @default.
- W2523096729 cites W1983960319 @default.
- W2523096729 cites W1991487652 @default.
- W2523096729 cites W1997261364 @default.
- W2523096729 cites W2002249283 @default.
- W2523096729 cites W2015504940 @default.
- W2523096729 cites W2026274122 @default.
- W2523096729 cites W2032411240 @default.
- W2523096729 cites W2039915339 @default.
- W2523096729 cites W2062941701 @default.
- W2523096729 cites W2087438037 @default.
- W2523096729 cites W2090642347 @default.
- W2523096729 cites W2095089320 @default.
- W2523096729 cites W2095841472 @default.
- W2523096729 cites W2101835294 @default.
- W2523096729 cites W2107005334 @default.
- W2523096729 cites W2122836009 @default.
- W2523096729 cites W2124537897 @default.
- W2523096729 cites W2125249832 @default.
- W2523096729 cites W2131432189 @default.
- W2523096729 cites W2139330350 @default.
- W2523096729 cites W2145284269 @default.
- W2523096729 cites W2149687213 @default.
- W2523096729 cites W2151547308 @default.
- W2523096729 cites W2180605142 @default.
- W2523096729 cites W2197811349 @default.
- W2523096729 cites W2324632859 @default.
- W2523096729 cites W4214754383 @default.
- W2523096729 doi "https://doi.org/10.1111/bcp.13131" @default.
- W2523096729 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5306496" @default.
- W2523096729 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27628437" @default.
- W2523096729 hasPublicationYear "2016" @default.
- W2523096729 type Work @default.
- W2523096729 sameAs 2523096729 @default.
- W2523096729 citedByCount "20" @default.
- W2523096729 countsByYear W25230967292019 @default.
- W2523096729 countsByYear W25230967292020 @default.
- W2523096729 countsByYear W25230967292021 @default.
- W2523096729 countsByYear W25230967292022 @default.
- W2523096729 countsByYear W25230967292023 @default.
- W2523096729 crossrefType "journal-article" @default.
- W2523096729 hasAuthorship W2523096729A5031789038 @default.
- W2523096729 hasAuthorship W2523096729A5036932318 @default.
- W2523096729 hasAuthorship W2523096729A5048242996 @default.
- W2523096729 hasAuthorship W2523096729A5065844847 @default.
- W2523096729 hasAuthorship W2523096729A5076511543 @default.
- W2523096729 hasAuthorship W2523096729A5078802906 @default.
- W2523096729 hasAuthorship W2523096729A5080990092 @default.
- W2523096729 hasBestOaLocation W25230967291 @default.
- W2523096729 hasConcept C112705442 @default.
- W2523096729 hasConcept C126322002 @default.
- W2523096729 hasConcept C159641895 @default.
- W2523096729 hasConcept C22979827 @default.
- W2523096729 hasConcept C2777288759 @default.
- W2523096729 hasConcept C2778335254 @default.
- W2523096729 hasConcept C2778651397 @default.
- W2523096729 hasConcept C2778980435 @default.
- W2523096729 hasConcept C2779489039 @default.
- W2523096729 hasConcept C2779541074 @default.
- W2523096729 hasConcept C2908647359 @default.
- W2523096729 hasConcept C42219234 @default.
- W2523096729 hasConcept C523546767 @default.
- W2523096729 hasConcept C54355233 @default.
- W2523096729 hasConcept C71924100 @default.
- W2523096729 hasConcept C86803240 @default.
- W2523096729 hasConcept C98274493 @default.
- W2523096729 hasConcept C99454951 @default.
- W2523096729 hasConceptScore W2523096729C112705442 @default.
- W2523096729 hasConceptScore W2523096729C126322002 @default.
- W2523096729 hasConceptScore W2523096729C159641895 @default.
- W2523096729 hasConceptScore W2523096729C22979827 @default.
- W2523096729 hasConceptScore W2523096729C2777288759 @default.
- W2523096729 hasConceptScore W2523096729C2778335254 @default.
- W2523096729 hasConceptScore W2523096729C2778651397 @default.
- W2523096729 hasConceptScore W2523096729C2778980435 @default.
- W2523096729 hasConceptScore W2523096729C2779489039 @default.
- W2523096729 hasConceptScore W2523096729C2779541074 @default.
- W2523096729 hasConceptScore W2523096729C2908647359 @default.
- W2523096729 hasConceptScore W2523096729C42219234 @default.
- W2523096729 hasConceptScore W2523096729C523546767 @default.
- W2523096729 hasConceptScore W2523096729C54355233 @default.
- W2523096729 hasConceptScore W2523096729C71924100 @default.